$FBIO
Fortress Biotech, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is FBIO up today? It is at $2.73 (+1.87%), and our scanner flagged it 20 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment FBIO spikes, and full due diligence on FBIO — key stats, earnings, dilution and insider activity. Free.
Get free $FBIO alerts the moment volume spikes
Our scanner flagged $FBIO 20 times in the last 30 days. Create a free account to track $FBIO, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $2.73
- Change today
- +1.87%
- Previous close
- $2.68
- 52-week range
- $2.18 – $4.53
- Market cap
- Stale Share count on file is from 2020, may predate a split
- Institutional own.
- 21.16%
- Total held
- 43.9%
- Tradeable float
- 46.3M 56% of shares · after 23% insiders + 21% institutions
- Short interest
- 5.6M ▼ -4% vs prior · as of 2026-08-14
- Short % of float
- 12.0%
- Days to cover
- 5.7d
- Avg daily volume
- 752K
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5m
- 0.3x
- 15m
- 0.2x
- 1h
- 0.4x
- 1D
- 0.4x
Get free FBIO + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $FBIO up today?
Here is the latest on FBIO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for FBIO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystFortress Biotech, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filingSC 13GPassive 5%+ stake disclosedSep 1, 2026 · todayAnalyst data via Nasdaq. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
Insiders
Insiders buying1 buys, 0 sells last 3 months (10/0 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Jin David Officer | Acquired (grant/award) | +400K 0.5% of company | added 32% | 1.65M | n/a | Jun 22, 26 |
Jin David Officer | Acquired (grant/award) | +3K | added 0.2% | 1.25M | $6K at $2.18 | Apr 1, 26 |
Weiss Michael S Officer | Acquired (grant/award) | +475K 0.6% of company | added 26% | 2.28M | n/a | Mar 18, 26 |
Rosenwald Lindsay A Md Officer | Acquired (grant/award) | +475K 0.6% of company | added 12% | 4.59M | n/a | Mar 18, 26 |
Hoenlein Malcolm Director | Acquired (grant/award) | +27K 0.03% of company | added 31% | 116K | n/a | Jan 1, 26 |
Lobell J Jay Director | Acquired (grant/award) | +27K 0.03% of company | added 17% | 192K | n/a | Jan 1, 26 |
Harvey Jimmie Director | Acquired (grant/award) | +27K 0.03% of company | added 23% | 147K | n/a | Jan 1, 26 |
Lorenz Kevin Director | Acquired (grant/award) | +27K 0.03% of company | added 37% | 101K | n/a | Jan 1, 26 |
Klein Dov Director | Acquired (grant/award) | +27K 0.03% of company | added 27% | 130K | n/a | Jan 1, 26 |
Jin David Officer | Acquired (grant/award) | +3K | added 0.2% | 1.25M | $4K at $1.31 | Oct 1, 25 |
Jin David Officer | Acquired (grant/award) | +5K | added 0.4% | 1.25M | $6K at $1.22 | Apr 1, 25 |
Rosenwald Lindsay A Md Officer | Acquired (grant/award) | +454K 0.6% of company | added 12% | 4.11M | n/a | Jan 1, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $FBIO runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 600,000 new shares
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$FBIO Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$FBIO Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to FBIO
Comparable names in pharmaceutical preparations, closest in size first.
FBIO stock FAQ
Why is $FBIO up today?
Here is the latest on FBIO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for FBIO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the FBIO stock price today?
FBIO last traded at $2.73, up 1.87% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live FBIO alerts?
The FBIO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged FBIO 20 times in the last 30 days.
What exchange is FBIO on?
FBIO (Fortress Biotech, Inc.) trades on XNAS, with a market cap of about $226M in the PHARMACEUTICAL PREPARATIONS sector.
Is FBIO good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge FBIO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.